Innovation in medicine: the first patient to receive gene therapy aimed at cell rejuvenation The American biotechnology company Life Biosciences announced last week that it has administered the first experimental treatment ER-100 to a patient suffering from glaucoma, one of the main causes of blindness. Sursa: Bursa https://www.bursa.ro/-innovation-in-medicine-the-first-patient-to-receive-gene-therapy-aimed-at-cell-rejuvenation-42592952